Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Æterna Zentaris Q4 Revenues Surges
Æterna Zentaris has posted a net income of $12.03m, or $0.19 per diluted share, compared to net loss of $14.49m, or $0.27 per diluted share, for the prior
Æterna Zentaris has posted a net income of $12.03m, or $0.19 per diluted share, compared to net loss of $14.49m, or $0.27 per diluted share, for the prior
Cedax was originally discovered by Shionogi and Co and licensed to Schering-Plough. Cedax had received marketing approval from the FDA in 1995. Indicated for mild to moderate acute
Bosch Packaging said that the new MHI 2020 vial filling and closing machine is specifically designed to handle liquid pharmaceuticals in small batches, making it ideal for clinical
Biotivia Bioceuticals said that the time release technology used in Transmax TR provides for a controlled release of the active ingredient over a 12 hour period. It gives
The study is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies, a subsidiary of Cosmo Pharmaceuticals, as part of the budesonide MMX Phase
The study, called Surpass, is expected to enroll 1,800 patients in 27 countries and provide direct comparative data of different treatment options for RRMS patients who experience breakthrough
The delivery system can be used for pharmaceutical, biopharmaceutical, medical foods, and nutraceutical products. In addition to the existing New Zealand patent, this patent covers the company’s multi-phase,
The gene expression assays are specifically designed for the workflow of Fluidigm’s integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers
The distribution agreement, announced in conjunction with positive data presented at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for
Phico has raised more than GBP3.7m during the last 12 months, bringing the total investment in the company to date to approximately GBP9m. Phico’s technology, known as SASPject,